Talk:Urinary bladder
Jump to navigation
Jump to search
ASP5878, a selective FGFR inhibitor, to treat FGFR3‐dependent urothelial cancer with or without chemoresistance https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329164/
ASP5878, a selective FGFR inhibitor, to treat FGFR3‐dependent urothelial cancer with or without chemoresistance https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329164/